The move comes following continued company growth across Europe and the US, with 10 of the Top 20 pharma/biotech companies now using Titian’s Mosaic sample management software. The larger US premises will house sales and support activities of Titian Software US.
Richard Fry, Commercial Director of Titian commented, “The US has always been an important market for Titian and today approximately half our installations are in the States. I am therefore delighted, despite the current economic climate, to be able to further invest in the US to strengthen our local customer support.” He continued, “Relocation to larger premises gives us room to recruit additional staff in the US to meet current demand and maintain our high level of customer service.”
Titian Software develops software products and consultancy services for the life science industries, specialising in sample management for drug discovery research. Mosaic is Titian Software’s comprehensive, modular software product developed to control and monitor all aspects of sample storage and preparation. These include sample inventory tracking and ordering, workflow management, control of third party robotic equipment such as automated stores and liquid handlers, and integration with existing IT systems.